Does LUSPATERCEPT Cause Deep vein thrombosis? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Deep vein thrombosis have been filed in association with LUSPATERCEPT (Reblozyl). This represents 2.3% of all adverse event reports for LUSPATERCEPT.
6
Reports of Deep vein thrombosis with LUSPATERCEPT
2.3%
of all LUSPATERCEPT reports
3
Deaths
2
Hospitalizations
How Dangerous Is Deep vein thrombosis From LUSPATERCEPT?
Of the 6 reports, 3 (50.0%) resulted in death, 2 (33.3%) required hospitalization.
Is Deep vein thrombosis Listed in the Official Label?
Yes, Deep vein thrombosis is listed as a known adverse reaction in the official FDA drug label for LUSPATERCEPT.
What Other Side Effects Does LUSPATERCEPT Cause?
Death (16)
Off label use (12)
Fatigue (11)
Anaemia (10)
Extramedullary haemopoiesis (10)
Pneumonia (10)
Drug ineffective (9)
Haemoglobin decreased (9)
Thrombocytopenia (9)
Cerebrovascular accident (8)
What Other Drugs Cause Deep vein thrombosis?
LENALIDOMIDE (3,286)
RIVAROXABAN (3,180)
TESTOSTERONE (2,213)
APIXABAN (1,944)
ETHINYL ESTRADIOL\ETONOGESTREL (1,577)
RITUXIMAB (1,287)
METHOTREXATE (1,146)
DROSPIRENONE\ETHINYL ESTRADIOL (1,139)
DEXAMETHASONE (1,067)
ADALIMUMAB (1,056)
Which LUSPATERCEPT Alternatives Have Lower Deep vein thrombosis Risk?
LUSPATERCEPT vs LUSPATERCEPT-AAMT
LUSPATERCEPT vs LUTEIN
LUSPATERCEPT vs LUTETIUM LU-177
LUSPATERCEPT vs LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
LUSPATERCEPT vs LUTETIUM OXODOTREOTIDE LU-177